We are live on ! Find out more
AIA

AIMZ Investment Advisors Portfolio holdings

AUM $324M
1-Year Est. Return 18.77%
This Fund
S&P 500
This Quarter Est. Return
-1.88%
1 Year Est. Return
+18.77%
3 Year Est. Return
+63.89%
5 Year Est. Return
+85.69%
10 Year Est. Return
+323.36%
AUM
$222M
AUM Growth
-$1.44M
Cap. Flow
+$3.73M
Cap. Flow %
1.69%
Top 10 Hldgs %
33.52%
Holding
116
New
2
Increased
28
Reduced
43
Closed
3

Top Buys

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$3.71M
2
VRTX icon
Vertex Pharmaceuticals
VRTX
+$3.12M
3
INCY icon
Incyte
INCY
+$1.92M
4
BMY icon
Bristol-Myers Squibb
BMY
+$678K
5
VTV icon
Vanguard Morningstar Value ETF
VTV
+$332K

Top Sells

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$5.42M
2
ADBE icon
Adobe
ADBE
+$189K
3
MSFT icon
Microsoft
MSFT
+$167K
4
QCOM icon
Qualcomm
QCOM
+$162K
5
HBAN icon
Huntington Bancshares
HBAN
+$162K

Sector Composition

Rank Sector Weight
1 Technology 32.38%
2 Healthcare 28.32%
3 Industrials 11.46%
4 Financials 8.63%
5 Consumer Discretionary 5.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DIS icon
101
Walt Disney
DIS
$181B
$272K 0.12%
1,608
– –
SCHV
102
Schwab US Large-Cap Value ETF
SCHV
$16.1B
$272K 0.12%
12,096
– –
PNC icon
103
PNC Financial Services
PNC
$101B
$264K 0.12%
1,351
– –
NVDA icon
104
NVIDIA
NVDA
$5.42T
$249K 0.11%
12,000
– –
HDV
105
iShares Core High Dividend ETF
HDV
$14.9B
$242K 0.11%
12,845
+60
+0.5% +$1.16K
V icon
106
Visa
V
$677B
$238K 0.11%
1,069
– –
NKE icon
107
Nike
NKE
$61.9B
$231K 0.1%
1,592
– –
ELV icon
108
Elevance Health
ELV
$85.5B
$220K 0.1%
590
– –
PLTR icon
109
Palantir
PLTR
$413B
$215K 0.1%
8,950
– –
RDS.A
110
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$214K 0.1%
4,800
-400
-8% -$16.1K
ALL icon
111
Allstate
ALL
$67.5B
$204K 0.09%
1,600
– –
NOK icon
112
Nokia
NOK
$52.3B
$132K 0.06%
24,200
– –
IVAC
113
DELISTED
Intevac Inc
IVAC
$120K 0.05%
25,045
– –
HBAN icon
114
Huntington Bancshares
HBAN
$35.5B
– –
-11,375
Closed -$162K
HTBK
115
DELISTED
Heritage Commerce
HTBK
– –
-10,612
Closed -$118K
ALXN
116
DELISTED
Alexion Pharmaceuticals
ALXN
– –
-29,485
Closed -$5.42M
1 2 3 4
5

Similar funds

UOC
University of Chicago Chicago, Illinois $323M AUM 14.1% 1-Year Est. Return
BCP
Bayberry Capital Partners New York $323M AUM 27.31% 1-Year Est. Return
AC
Athos Capital Hong Kong $324M AUM 16.62% 1-Year Est. Return
TM
Tikvah Management Charlotte, North Carolina $323M AUM 69.61% 1-Year Est. Return
THCM
Taylor Hoffman Capital Management Richmond, Virginia $325M AUM 27.67% 1-Year Est. Return
WG
Wellington Group Indianapolis, Indiana $325M AUM
DMC
DSC Meridian Capital New York $325M AUM 45.4% 1-Year Est. Return
BEP
Bluescape Energy Partners Dallas, Texas $322M AUM 18.33% 1-Year Est. Return

AIMZ Investment Advisors's Q3 2021 Portfolio in Review

As of Q3 2021, AIMZ Investment Advisors held 116 positions worth $222M, down 0.65% from $223M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Trading was light in Q3 2021: portfolio turnover was 4.3%. AIMZ Investment Advisors opened 2 new positions and exited 3, leaving the 116-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 32% a quarter earlier, followed by Healthcare and Industrials.

  • AIMZ Investment Advisors's largest Q3 2021 buy was AstraZeneca: 31,904 shares worth $3.83M.
  • AIMZ Investment Advisors added most to Vertex Pharmaceuticals in Q3 2021, an estimated $3.12M increase.
  • AIMZ Investment Advisors's biggest Q3 2021 reduction was Adobe, cutting an estimated $189K.
  • AIMZ Investment Advisors fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $5.42M.
  • AIMZ Investment Advisors's ten largest holdings make up 34% of its $222M portfolio in Q3 2021.
  • AIMZ Investment Advisors opened 2 new positions and closed 3 in Q3 2021.
  • AIMZ Investment Advisors's portfolio value fell 0.65% quarter-over-quarter to $222M.

Based on AIMZ Investment Advisors's 13F filing for Q3 2021, filed 12 Nov 2021.